Tri-2-Hydroxyarachidonein Induces Cytocidal Autophagy in Pancreatic Ductal Adenocarcinoma Cancer Cell Models.

autophagy cancer cell death oncology pancreas signal transduction synthetic lipid

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2021
Historique:
received: 24 09 2021
accepted: 28 10 2021
entrez: 7 2 2022
pubmed: 8 2 2022
medline: 8 2 2022
Statut: epublish

Résumé

Cell proliferation in pancreatic cancer is determined by a complex network of signaling pathways. Despite the extensive understanding of these protein-mediated signaling processes, there are no significant drug discoveries that could considerably improve a patient's survival. However, the recent understanding of lipid-mediated signaling gives a new perspective on the control of the physiological state of pancreatic cells. Lipid signaling plays a major role in the induction of cytocidal autophagy and can be exploited using synthetic lipids to induce cell death in pancreatic cancer cells. In this work, we studied the activity of a synthetic lipid, tri-2-hydroxyarachidonein (TGM4), which is a triacylglycerol mimetic that contains three acyl moieties with four double bonds each, on cellular and

Identifiants

pubmed: 35126175
doi: 10.3389/fphys.2021.782525
pmc: PMC8811354
doi:

Types de publication

Journal Article

Langues

eng

Pagination

782525

Informations de copyright

Copyright © 2022 Fernández-Díaz, Beteta-Göbel, Torres, Cabot, Fernández-García, Lladó, Escribá and Busquets.

Déclaration de conflit d'intérêts

PF-G and VL were employed by company Laminar Pharmaceuticals. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
pubmed: 19474385
Autophagy. 2007 Jul-Aug;3(4):323-8
pubmed: 17387262
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4318-23
pubmed: 9113987
Cancer Res. 2006 Jun 15;66(12):5977-80
pubmed: 16778164
F1000Res. 2020 Feb 21;9:
pubmed: 32148767
JAMA. 2001 Aug 22-29;286(8):921-9
pubmed: 11509056
J Biol Chem. 2003 Aug 1;278(31):29278-87
pubmed: 12740394
Science. 2008 Sep 26;321(5897):1801-6
pubmed: 18772397
J Biol Chem. 1951 Nov;193(1):265-75
pubmed: 14907713
J Biol Chem. 2000 Sep 1;275(35):27447-56
pubmed: 10862611
Biochem Biophys Res Commun. 2006 Jan 6;339(1):437-42
pubmed: 16300744
Clin Sci (Lond). 2009 May;116(9):697-712
pubmed: 19323652
Biochem Pharmacol. 2019 Oct;168:57-64
pubmed: 31207211
World J Gastroenterol. 2014 Mar 7;20(9):2279-303
pubmed: 24605027
Diabetologia. 2003 Mar;46(3):365-77
pubmed: 12687335
PLoS One. 2012;7(10):e48235
pubmed: 23133576
Front Oncol. 2020 Oct 28;10:577420
pubmed: 33194695
Biochem Biophys Res Commun. 2011 Oct 14;414(1):53-9
pubmed: 21945432
Int J Biochem Cell Biol. 2004 Dec;36(12):2435-44
pubmed: 15325583
Cell Signal. 2014 Jul;26(7):1385-91
pubmed: 24657471
Nat Rev Cancer. 2005 Sep;5(9):726-34
pubmed: 16148885
Int J Mol Sci. 2019 May 01;20(9):
pubmed: 31052427
J Pharmacol Exp Ther. 2015 Aug;354(2):213-24
pubmed: 26065701
Front Immunol. 2019 Jan 04;9:3083
pubmed: 30662442
Int Rev Cell Mol Biol. 2020;352:159-187
pubmed: 32334815
Cancers (Basel). 2019 Jan 14;11(1):
pubmed: 30646599
Genes Dev. 2013 Feb 15;27(4):429-40
pubmed: 23392608
JAMA. 1995 May 24-31;273(20):1605-9
pubmed: 7745774
Cancer Res. 2007 Nov 15;67(22):10631-4
pubmed: 18006802
JAMA. 2000 May 17;283(19):2552-8
pubmed: 10815119
Glia. 2002 Aug;39(2):105-13
pubmed: 12112362
Nature. 2000 Nov 23;408(6811):488-92
pubmed: 11100732
Biochimie. 2003 Mar-Apr;85(3-4):455-63
pubmed: 12770784
Autophagy. 2017 Jan 2;13(1):216-217
pubmed: 27791469
Cancer Lett. 2005 Jul 8;225(1):141-9
pubmed: 15922866
Biochem Biophys Res Commun. 2014 Mar 7;445(2):524-33
pubmed: 24565834
Nature. 2015 Feb 26;518(7540):495-501
pubmed: 25719666
Cell Cycle. 2008 Oct;7(19):3021-5
pubmed: 18802406
Br J Cancer. 2005 Jun 6;92(11):2076-83
pubmed: 15886696
Essays Biochem. 2013;55:105-17
pubmed: 24070475
Redox Biol. 2018 May;15:316-326
pubmed: 29306194
J Hepatol. 2013 Sep;59(3):583-94
pubmed: 23567086
Cancers (Basel). 2021 Aug 26;13(17):
pubmed: 34503102
Nature. 2008 Feb 28;451(7182):1069-75
pubmed: 18305538
Int J Cancer. 2010 Dec 15;127(12):2893-917
pubmed: 21351269
Mol Cell Biochem. 2003 Nov;253(1-2):65-70
pubmed: 14619957
J Biol Chem. 2004 Nov 12;279(46):47704-10
pubmed: 15355958
Genes Dev. 1994 Feb 15;8(4):453-64
pubmed: 8125258
Autophagy. 2007 Sep-Oct;3(5):452-60
pubmed: 17534139
Br J Cancer. 2021 Jan;124(2):333-344
pubmed: 32929194
EMBO J. 2015 Apr 15;34(8):1025-41
pubmed: 25586377
J Biol Chem. 1998 Dec 11;273(50):33533-9
pubmed: 9837934
Oncogene. 2000 Oct 26;19(45):5173-81
pubmed: 11064454
J Cancer. 2016 Jul 07;7(11):1497-514
pubmed: 27471566
Int J Biochem Mol Biol. 2011 Jan 1;2(1):89-98
pubmed: 21331354
Lipids Health Dis. 2020 Sep 30;19(1):214
pubmed: 32998777
Proc Natl Acad Sci U S A. 2012 May 29;109(22):8489-94
pubmed: 22586083
Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2380-5
pubmed: 19723916
Cell Death Differ. 2007 Feb;14(2):230-9
pubmed: 16794605
P R Health Sci J. 2004 Jun;23(2):103-6
pubmed: 15377057
Exp Ther Med. 2017 May;13(5):2348-2354
pubmed: 28565848
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13754-8
pubmed: 19666584
Mol Cell Biol. 2006 Dec;26(24):9220-31
pubmed: 17030611
EMBO J. 2000 Nov 1;19(21):5720-8
pubmed: 11060023
Science. 2012 Nov 16;338(6109):956-9
pubmed: 23112296
J Cell Biol. 2008 Oct 6;183(1):101-16
pubmed: 18838554
Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
pubmed: 388439

Auteurs

Javier Fernández-Díaz (J)

Laboratory of Molecular Cell Biomedicine, Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.

Roberto Beteta-Göbel (R)

Laboratory of Molecular Cell Biomedicine, Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.

Manuel Torres (M)

Laboratory of Molecular Cell Biomedicine, Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.

Joan Cabot (J)

Laboratory of Molecular Cell Biomedicine, Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.

Paula Fernández-García (P)

Laminar Pharmaceuticals, Department of R&D, Palma de Mallorca, Spain.

Victoria Lladó (V)

Laminar Pharmaceuticals, Department of R&D, Palma de Mallorca, Spain.

Pablo V Escribá (PV)

Laboratory of Molecular Cell Biomedicine, Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.

Xavier Busquets (X)

Laboratory of Molecular Cell Biomedicine, Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.

Classifications MeSH